Advertisement
New Zealand markets close in 2 hours 25 minutes
  • NZX 50

    11,882.27
    +8.23 (+0.07%)
     
  • NZD/USD

    0.5971
    +0.0008 (+0.14%)
     
  • NZD/EUR

    0.5559
    +0.0003 (+0.06%)
     
  • ALL ORDS

    7,898.40
    +49.00 (+0.62%)
     
  • ASX 200

    7,631.90
    +44.90 (+0.59%)
     
  • OIL

    79.07
    +0.12 (+0.15%)
     
  • GOLD

    2,309.00
    -0.60 (-0.03%)
     
  • NASDAQ

    17,541.54
    +222.99 (+1.29%)
     
  • FTSE

    8,172.15
    +50.91 (+0.63%)
     
  • Dow Jones

    38,225.66
    +322.37 (+0.85%)
     
  • DAX

    17,896.50
    -35.67 (-0.20%)
     
  • Hang Seng

    18,460.36
    +253.23 (+1.39%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • NZD/JPY

    91.3220
    -0.2530 (-0.28%)
     

New Strong Buy Stocks for April 17th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Byrna Technologies Inc. BYRN:  This non-lethal defense technology companyhas seen the Zacks Consensus Estimate for its current year earnings increasing 157.1% over the last 60 days.

Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. Price and Consensus
Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote

Y-mAbs Therapeutics, Inc. YMAB: This commercial-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 42.7% over the last 60 days.

Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. Price and Consensus
Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. price-consensus-chart | Y-mAbs Therapeutics, Inc. Quote

ADVERTISEMENT

Sandstorm Gold Ltd. SAND: This gold royalty company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.

Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd Price and Consensus
Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd price-consensus-chart | Sandstorm Gold Ltd Quote

Corcept Therapeutics Incorporated CORT: This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.

Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated Price and Consensus
Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated price-consensus-chart | Corcept Therapeutics Incorporated Quote

Enveric Biosciences, Inc. ENVB: This biotechnology company has seen the Zacks Consensus Estimate for its next year earnings increasing 25.6% over the last 60 days.

Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. Price and Consensus
Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. price-consensus-chart | Enveric Biosciences, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Corcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report

Sandstorm Gold Ltd (SAND) : Free Stock Analysis Report

Y-mAbs Therapeutics, Inc. (YMAB) : Free Stock Analysis Report

Byrna Technologies Inc. (BYRN) : Free Stock Analysis Report

Enveric Biosciences, Inc. (ENVB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research